Tender Details | ||||||||
|
||||||||
Deadline * | ||||||||
|
||||||||
Client Address | ||||||||
|
||||||||
More Information | ||||||||
Know More |
Similar Tenders
- Ref No: 9213203
- Location: China
Public Bidding Announcement For The Ningbo Vocational And Technical College Digital Textbook Construction Publishing Services Project
- Deadline: 30 Nov 2025
- Ref No: 9259628
- Location: Kenya
Construction Of 1 No Ecde Classroom At Kebee And Kopsiro Primary School In Chepyuk Ward
- Deadline: 09 Oct 2025
- Ref No: 9322250
- Location: Brazil
Project More Digital Sao Paulo Project Br L1591
- Deadline: 28 Dec 2028
- Ref No: 9868439
- Location: United States
Open Ended School Based Health Center Services Sbhc Rfp
- Deadline: 31 Dec 2099
- Ref No: 9877633
- Location: Estonia
Organization Of A One Stage Design Competition Landscape Architecture Competition Of The Garden Of Ukraine
- Deadline: 09 Oct 2025
- Ref No: 5304541
- Location: Netherlands
Career Paths Construction Technology And Green
- Deadline: 30 Apr 2026
- Ref No: 5306291
- Location: Germany
Open House Drug Discount Agreements Rivaroxaban Film Coated Tablets Except With A Strength Of 2 5 Mg Atc B01Af01
- Deadline: 05 Apr 2026
- Ref No: 5304038
- Location: Germany
Open House Drug Discount Contracts In Accordance With Section 130A Paragraph 8C Sgb V Pemetrexed Atc L01Ba04
- Deadline: 16 Apr 2026
- Ref No: 5310172
- Location: Germany
Open House Drug Discount Contracts In Accordance With Section 130A Paragraph 8C Sgb V Bortezomib Atc L01Xg01
- Deadline: 16 Apr 2026
- Ref No: 5332318
- Location: Germany
Dynamic Procurement System Dbs For Green Electricity Deliveries From 2025 For The City Of Wolfsburg
- Deadline: 23 Apr 2026
- Ref No: 4642060
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredie
- Deadline: 28 Feb 2026
- Ref No: 4646012
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredie
- Deadline: 28 Feb 2026